recent publications

• academic article

  • Gamage, T. F., Ignatowska-Jankowsa, B. M., Muldoon, P. P., Cravatt, B. F., Damaj, M. I., Lichtman, A. H. Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice Drug and Alcohol Dependence  2015 146:7-16  DOI:10.1016/j.drugalcdep.2014.11.015  PMID:25479915  PMCID:PMC4295928
  • Muldoon, P. P., Chen, J., Harenza, J. L., Abdullah, R. A., Sim-Selley, L. J., Cravatt, B. F., Miles, M. F., Chen, X., Lichtman, A. H., Damaj, M. I. Inhibition of monoacylglycerol lipase reduces nicotine withdrawal British Journal of Pharmacology  2015 172:869-882  DOI:10.1111/bph.12948  PMID:25258021  PMCID:PMC4301695
  • Wieskopf, J. S., Mathur, J., Limapichat, W., Post, M. R., Al-Qazzaz, M., Sorge, R. E., Martin, L. J., Zaykin, D. V., Smith, S. B., Freitas, K., Austin, J. S., Dai, F., et al. The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors Science Translational Medicine  2015 7:287ra72  DOI:10.1126/scitranslmed.3009986  PMID:25972004  PMCID:PMC5018401
  • Muldoon, P. P., Lichtman, A. H., Parsons, L. H., Damaj, M. I. The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence Life Sciences  2013 92:458-462  DOI:10.1016/j.lfs.2012.05.015  PMID:22705310  PMCID:PMC3477273
  • Tobey, K. M., Walentiny, D. M., Wiley, J. L., Carroll, F. I., Damaj, M. I., Azar, M. R., Koob, G. F., George, O., Harris, L. S., Vann, R. E. Effects of the specific alpha 4 beta 2 nachr antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice Psychopharmacology  2012 223:159-168  DOI:10.1007/s00213-012-2703-3  PMID:22526534  PMCID:PMC3464481
  • George, O., Lloyd, A., Carroll, F. I., Damaj, M. I., Koob, G. F. Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration Psychopharmacology  2011 213:715-722  DOI:10.1007/s00213-010-2024-3  PMID:20924754  PMCID:PMC3033995